The in Cary, North Carolina, has announced a four-year, $1 million grant that will fund collaborative research between the and the at the University of North Carolina, Chapel Hill.
Together, researchers at both universities will dissect the complexities of breast cancer, with the common goal of developing strategies for individualized treatments that build on prior work and advancements at both institutions. The project will further the studies of Dr. Charles Perou of UNC, whose work has focused on patients with unlikely prognoses or hereditary breast cancers, and Dr. Joseph Nevins of Duke, whose work has enabled other physicians to select the right anti-cancer drugs for their patients.
Out of this project, the foundation hopes to develop a treatment model it can replicate throughout the country, said foundation CEO Nick Valvano, brother of the late founder Jim Valvano. "We hope this project will play a role in shaping how future breast cancer patients will be diagnosed and treated."